Opus Point Partners Management’s Epizyme, Inc EPZM Stock Holding History

Opus Point Partners Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$520K	Hold	50,378	–	–	0.94%	25
2019 Q2	$632K	Hold	50,378	–	–	0.94%	29
2019 Q1	$624K	Buy	+50,378	New	+$563K	0.85%	26
2016 Q2	–	Sell	-189,564	Closed	-$2.3M	–	54
2016 Q1	$2.3M	Buy	189,564 +53,937	+40%	+$546K	1.78%	23
2015 Q4	$2.17M	Buy	135,627 +89,548	+194%	+$1.33M	1.44%	24
2015 Q3	$593K	Sell	46,079 -26,300	-36%	-$531K	0.33%	41
2015 Q2	$1.74M	Buy	72,379 +24,040	+50%	+$463K	1.38%	27
2015 Q1	$908K	Buy	48,339 +20,000	+71%	+$413K	0.76%	34
2014 Q4	$535K	Buy	+28,339	New	+$662K	0.53%	48

Other funds holding EPZM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Opus Point Partners Management's EPZM Position: Q3 2019 in Review

Opus Point Partners Management held its Epizyme, Inc (EPZM) position steady in Q3 2019 at 50,378 shares worth $520K. The position accounts for 0.94% of the portfolio, ranked #25.

Opus Point Partners Management first reported a position in EPZM in Q4 2014 and has held it in 9 quarters since. The position peaked at $2.3M in Q1 2016. 115 funds tracked by Wall St. Rank hold EPZM as of Q3 2019.

Opus Point Partners Management held 50,378 shares of Epizyme, Inc worth $520K as of Q3 2019.
Opus Point Partners Management left its Epizyme, Inc share count unchanged in Q3 2019.
Epizyme, Inc made up 0.94% of Opus Point Partners Management's portfolio in Q3 2019, its #25 holding.
Opus Point Partners Management first reported a position in Epizyme, Inc in Q4 2014 and has held it in 9 quarters since.
Opus Point Partners Management's Epizyme, Inc position peaked at $2.3M in Q1 2016.
115 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.